EPIRIUM Trademark

Trademark Overview

On Monday, September 9, 2019, a trademark application was filed for EPIRIUM with the United States Patent and Trademark Office. The USPTO has given the EPIRIUM trademark a serial number of 88609986. The federal status of this trademark filing is REGISTERED as of Tuesday, June 7, 2022. This trademark is owned by Cardero Therapeutics, Inc.. The EPIRIUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of neurodegenerative and mitochondrial diseases and disorders; pharmaceuticals for the treatment of diseases and disorders that affect movement; steroids
epirium

General Information

Serial Number88609986
Word MarkEPIRIUM
Filing DateMonday, September 9, 2019
Status700 - REGISTERED
Status DateTuesday, June 7, 2022
Registration Number6754757
Registration DateTuesday, June 7, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2020

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of neurodegenerative and mitochondrial diseases and disorders; pharmaceuticals for the treatment of diseases and disorders that affect movement; steroids
Pseudo MarkEMPORIUM

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 19, 2019
Primary Code005
First Use Anywhere DateMonday, August 31, 2020
First Use In Commerce DateMonday, August 31, 2020

Trademark Owner History

Party NameEPIRIUM BIO INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92122
Party NameEPIRIUM BIO INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92122
Party NameCardero Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameCardero Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Wednesday, December 20, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, December 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 7, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 7, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, May 4, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 3, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 7, 2022ASSIGNED TO LIE
Friday, March 4, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, September 27, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, September 27, 2021FINAL REFUSAL E-MAILED
Monday, September 27, 2021SU - FINAL REFUSAL - WRITTEN
Tuesday, August 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 6, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 6, 2021NON-FINAL ACTION E-MAILED
Tuesday, April 6, 2021SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 16, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 24, 2021USE AMENDMENT FILED
Monday, March 15, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 24, 2021TEAS STATEMENT OF USE RECEIVED
Friday, September 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 9, 2020SOU EXTENSION 1 GRANTED
Wednesday, September 9, 2020SOU EXTENSION 1 FILED
Wednesday, September 9, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, August 5, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 10, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 10, 2019ASSIGNED TO EXAMINER
Thursday, September 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 12, 2019NEW APPLICATION ENTERED

Related Keywords

epirium disorders pharmaceuticals diseases treatment steroids movement affect mitochondrial neurodegenerative